{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:31:04Z","timestamp":1786728664088,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Management of neonatal seizures with available limited guidelines across different gestation can cause long-term neurological and cognitive impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To compare utilization and observe the efficacy of anti-epileptic drugs in the treatment of neonatal seizures. The association of hypoxic-ischemic encephalopathy with NS and the etiology of HIE were also determined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and Methods:<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted at a tertiary care hospital for a period of one year. It was approved by IEC prior to initiation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants:<\/jats:title>\n                    <jats:p>Neonates admitted for seizure management and perinatal asphyxia with hypoxic-ischemic encephalopathy were included in the study. Both term and preterm 267 neonates from January 2014 to July 2018 were retrospectively analyzed. The drugs with the fastest seizure resolution, least recurrence, and readmission rates were considered efficient. Phenobarbitone, levetiracetam, and phenytoin were compared as they were commonly prescribed. Inpatient medical records and hospital databases served as sources of information.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Phenobarbitone was commonly utilized, followed by phenytoin and levetiracetam. The commonly prescribed combination was phenobarbitone (first-line agent) and phenytoin (second-line agent). Phenobarbitone immediately resolved seizures (97, 75.1%) and had the least cases of seizure recurrences (53, 41.1%) and readmissions (20, 15.5%), making it most efficient. The best second-line agent was phenytoin, with the least seizure recurrence (4, 8.51%), least readmissions (7, 14.8%), and fastest resolution (25, 53.1%). Levetiracetam was an efficient third-line agent. Hypoxic-ischemic encephalopathy was the most observed cause of neonatal seizures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Phenobarbitone was observed as the most utilized and efficient anti-epileptic drug, followed by phenytoin and levetiracetam. Owing to limitations in this study, there is an alarming need for standardized clinical trials to establish thorough guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0028-3886.344647","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T04:05:56Z","timestamp":1692849956000},"page":"574-578","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and Utilization Patterns of Anti-Epileptic Drugs in the Management of Neonatal Seizures: A Comparative Exploration"],"prefix":"10.4103","volume":"70","author":[{"given":"Rose B","family":"Thomas","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, Manipal College of Pharmceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spandana Siri","family":"Muttavarapu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Manipal College of Pharmceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanna K","family":"Shetty","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Manipal College of Pharmceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie E","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Kasturba Medical College, Manipal, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,5,3]]},"reference":[{"key":"R1-20260803","doi-asserted-by":"crossref","first-page":"100","DOI":"10.18203\/2349-3291.ijcp20164586","article-title":"Assessment of developmental outcome of neonatal seizures at NICU of tertiary care center hospital","volume":"4","author":"Saral","year":"2017","journal-title":"Int J Contemp Pediatr"},{"key":"R2-20260803","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1001\/jamapediatrics.2017.5211","article-title":"Comparative effectiveness of levetiracetam vs phenobarbital for infantile epilepsy","volume":"4","author":"Grinspan","year":"2018","journal-title":"JAMA Pediatr"},{"key":"R3-20260803","first-page":"131","article-title":"Management of neonatal seizures- A focus on neuropharmacological aspects","volume":"3","author":"Dias","year":"2018","journal-title":"Pediatr Neonat Biol"},{"key":"R5-20260803","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/jp.2016.206","article-title":"Changing antiepileptic drug use in neonatal intensive care units from year 2014 to 2015","volume":"37","author":"Ahmad","year":"2017","journal-title":"J Perinatol"},{"key":"R6-20260803","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fped.2015.00101","article-title":"Neonatal seizures: Impact on neurodevelopmental outcomes","volume":"3","author":"Kang","year":"2015","journal-title":"Front Pediatr"},{"key":"R7-20260803","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/ana.24967","article-title":"Phenobarbitone and midazolam increase neonatal seizure associated injury","volume":"82","author":"Torolira","year":"2017","journal-title":"Ann Neurol"},{"key":"R8-20260803","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s13312-019-1586-3","article-title":"Levetiracetam versus phenobarbitone in neonatal seizures- A randamized clinical trial","volume":"56","author":"Gowda","year":"2019","journal-title":"Ind Pediatr"},{"key":"R9-20260803","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/RRN.S39714","article-title":"Management of refractory seizures","volume":"4","author":"Neubauer","year":"2014","journal-title":"Research and Reports in Neonatology"},{"key":"R10-20260803","first-page":"145","article-title":"Levetiracetam versus phenobarbitone for neonatal seizures: A randomized controlled trail","volume":"6","author":"Sharpe","year":"2020","journal-title":"Pediatrics"},{"key":"R11-20260803","first-page":"327","article-title":"Etiology of neonatal seizures","volume":"5","author":"Hahn","year":"2004","journal-title":"Neo Rev"},{"key":"R12-20260803","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199908123410704","article-title":"Phenobarbital compared with phenytoin for the treatment of neonatal seizures","volume":"341","author":"Painter","year":"1999","journal-title":"N Engl J Med"},{"key":"R13-20260803","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s13312-013-0218-6","article-title":"Phenobarbitone versus phenytoin for treatment of neonatal seizures: An open ended randomized controlled trial","volume":"50","author":"Pathak","year":"2013","journal-title":"Indian Pediatr"},{"key":"R14-20260803","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/ped.13554","article-title":"Midazolam as first line agent for neonatal seizures: Retrospective study","volume":"60","author":"Dao","year":"2018","journal-title":"Pediatr Int"},{"key":"R15-20260803","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-3476(99)70374-4","article-title":"The epidemiology of clinical neonatal seizures in newfoundland: A population-based study","volume":"134","author":"Ronen","year":"1999","journal-title":"J Pediatr"},{"key":"R16-20260803","first-page":"76","article-title":"Levetiracetam in neonatal seizures: A review","volume":"20","author":"Mruk","year":"2015","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R17-20260803","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5698\/1535-7511-11.5.147","article-title":"Neonatal seizures due to hypoxic-ischemic encephalopathy: Should we care?","volume":"5","author":"Kossoff","year":"2011","journal-title":"Epilepsy Curr"},{"key":"R18-20260803","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.21167","article-title":"Neonatal seizures","volume":"62","author":"Silverstein","year":"2007","journal-title":"Ann Neurol"},{"key":"R19-20260803","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1651-2227.1995.tb13794.x","article-title":"Birth asphyxia: Incidence, clinical course and outcome in a Swedish population","volume":"84","author":"Thornberg","year":"1995","journal-title":"Acta Paediatr"},{"key":"R20-20260803","doi-asserted-by":"crossref","first-page":"113","DOI":"10.17712\/1658-3183.1204","article-title":"Hypoxic ischemic encephalopathy: Incidence, risk factors in North Western Saudi Arabia","volume":"8","author":"Itoo","year":"2003","journal-title":"Neuroscience"}],"container-title":["Neurology India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.344647","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:30:08Z","timestamp":1786725008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.344647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/0028-3886.344647","relation":{},"ISSN":["0028-3886","1998-4022"],"issn-type":[{"value":"0028-3886","type":"print"},{"value":"1998-4022","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"2020-04-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}